Published on in Vol 6, No 9 (2017): September

Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol

Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol

Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol

Journals

  1. Lynch H, Nustas R, Kassim T, Snyder C, Shaw T, Diab O. The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example. Cancer Genetics 2019;233-234:43 View
  2. Frey M, Kahn R, Chapman-Davis E, Tubito F, Pires M, Christos P, Anderson S, Mukherjee S, Jordan B, Blank S, Caputo T, Sharaf R, Offit K, Holcomb K, Lipkin S. Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling. Journal of Clinical Oncology 2020;38(13):1389 View
  3. Rutgers E, Balmana J, Beishon M, Benn K, Evans D, Mansel R, Pharoah P, Perry Skinner V, Stoppa-Lyonnet D, Travado L, Wyld L. European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer. European Journal of Cancer 2019;106:45 View
  4. Menko F, Jeanson K, Bleiker E, van Tiggelen C, Hogervorst F, ter Stege J, Ait Moha D, van der Kolk L. The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure. European Journal of Human Genetics 2020;28(8):1020 View
  5. Menko F, ter Stege J, van der Kolk L, Jeanson K, Schats W, Moha D, Bleiker E. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Familial Cancer 2019;18(1):127 View
  6. Reid S, Spalluto L, Pal T. Strategies to enhance identification of hereditary breast cancer gene carriers. Expert Review of Molecular Diagnostics 2020;20(9):861 View
  7. Dean M, Tezak A, Johnson S, Pierce J, Weidner A, Clouse K, Pal T, Cragun D. Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers. Patient Education and Counseling 2021;104(4):720 View
  8. Cragun D, Weidner A, Tezak A, Clouse K, Pal T. Family communication of genetic test results among women with inherited breast cancer genes. Journal of Genetic Counseling 2021;30(3):701 View
  9. Nitecki R, Moss H, Watson C, Urbauer D, Melamed A, Lu K, Lipkin S, Offit K, Rauh-Hain J, Frey M. Facilitated cascade testing (FaCT): a randomized controlled trial. International Journal of Gynecologic Cancer 2021;31(5):779 View
  10. Kaphingst K, Kohlmann W, Chambers R, Goodman M, Bradshaw R, Chan P, Chavez-Yenter D, Colonna S, Espinel W, Everett J, Gammon A, Goldberg E, Gonzalez J, Hagerty K, Hess R, Kehoe K, Kessler C, Kimball K, Loomis S, Martinez T, Monahan R, Schiffman J, Temares D, Tobik K, Wetter D, Mann D, Kawamoto K, Del Fiol G, Buys S, Ginsburg O. Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial. BMC Health Services Research 2021;21(1) View
  11. Kim S, Aceti M, Baroutsou V, Bürki N, Caiata-Zufferey M, Cattaneo M, Chappuis P, Ciorba F, Graffeo-Galbiati R, Heinzelmann-Schwarz V, Jeong J, Jung M, Kim S, Kim J, Lim M, Ming C, Monnerat C, Park H, Park S, Pedrazzani C, Rabaglio M, Ryu J, Saccilotto R, Wieser S, Zürrer-Härdi U, Katapodi M. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study. JMIR Research Protocols 2021;10(6):e26264 View

Books/Policy Documents

  1. . Constitutional Oncogenetics. View